Introgen Therapeutics, Inc.

(NASDAQ:INGN)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Cash Flow Statement
Cash At Beginning Of Period 11,320 11,320 11,320 25,578
Cash At End Of Period 6,294 11,016 16,479 11,320
Net Change In Cash And Cash Equivalents -5,026 -304 5,159 -14,258
Effect Of Exchange Rate Changes -51 24 39 -6
Net Income Or Loss -14,722 -8,747 -2,401 -30,455
Cash From Operating Activities
Depreciation Expenses 746 495 247 1,018
Amortization Expenses
Amortization Of Intangibles Expenses
Deferred Income Taxes
Operating Gains Or Losses -4,392 -4,392 -4,392 6
Extraordinary Gains Or Losses
Increase Or Decrease In Receivables
Increase Or Decrease In Inventories
Increase Or Decrease In Prepaid Expenses
Increase Or Decrease In Other Current Assets
Increase Or Decrease In Payables
Increase Or Decrease In Other Current Liabilities 769 1,068 1,232 -571
Increase Or Decrease In Other Working Capital -1,437 -1,715 -1,382 910
Other Non Cash Items 352 183 113 -836
Net Cash From Continuing Operations 3,302 2,183 1,045 5,982
Net Cash From Discontinued Operations -15,382 -10,925 -5,538 -23,946
Net Cash From Operating Activities
Cash From Investing Activities
Sale Of Property Plant And Equipment
Sale Of Long Term Investments
Sale Of Short Term Investments
Purchase Of Property Plant And Equipment -167 -117 -126 -288
Acquisitions
Purchase Of Long Term Investments
Purchase Of Short Term Investments -29,553
Other Investing Changes Net
Cash From Discontinued Investing Activities
Net Cash From Investing Activities 10,847 10,897 10,888 11,894
Cash From Financing Activities
Issuance Of Debt 86 25 19 296
Issuance Of Capital Stock -484 -333 -174 -906
Repayment Of Debt -200
Repurchase Of Capital Stock
Payment Of Cash Dividends -150 -75 -1,872
Net Other Financing Charges -150 -75 -1,872
Cash From Discontinued Financing Activities
Net Cash From Financing Activities -440 -300 -230 -2,200